Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Autologous BMT"'
Autor:
Sandra Fernandes, Robert Brooks, Matthew Gumbleton, Mi-Young Park, Christopher M. Russo, Kyle T. Howard, John D. Chisholm, William G. Kerr
Publikováno v:
EBioMedicine, Vol 2, Iss 3, Pp 205-213 (2015)
Hematopoietic stem cell transplantation (HSCT) is a highly effective procedure enabling long-term survival for patients with hematologic malignancy or heritable defects. Although there has been a dramatic increase in the success rate of HSCT over the
Externí odkaz:
https://doaj.org/article/803f7a54adcc4a47933a44e24a5b299d
Autor:
Afif Mufarrij, Sarah S. Abdul-Nabi, Imad El Majzoub, Hani Tamim, Rola Cheaito, Jean El Cheikh, Maha Makki, Mohamad Ali Cheaito
Publikováno v:
The American Journal of Emergency Medicine. 45:117-123
Background Despite the advantages of bone marrow transplantation (BMT), patients receiving this intervention visit the emergency department (ED) frequently and for various reasons. Many of those ED visits result in hospitalization, and the length of
Autor:
Matthew Gumbleton, Kyle T. Howard, John D. Chisholm, Mi Young Park, Sandra Fernandes, Robert Brooks, Christopher M. Russo, William G. Kerr
Publikováno v:
EBioMedicine
EBioMedicine, Vol 2, Iss 3, Pp 205-213 (2015)
EBioMedicine, Vol 2, Iss 3, Pp 205-213 (2015)
Hematopoietic stem cell transplantation (HSCT) is a highly effective procedure enabling long-term survival for patients with hematologic malignancy or heritable defects. Although there has been a dramatic increase in the success rate of HSCT over the
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Biology of Blood and Marrow Transplantation. 17:330-340
Vaccination with irradiated autologous tumor cells, engineered to secrete granulocyte macrophage colony stimulating factor (GM-CSF) (GM-tumor), can generate potent anti-tumor effects when combined with autologous bone marrow transplantation (BMT). Th
Autor:
Tiago Pinto, Thyago M. Espírito Santo, Luciana Landeiro, Thereza Christina Cruz Dias, Ledivia Espinheira, Ronald Pallotta, Flávia Cal
Publikováno v:
Brazilian Journal of Transplantation. 8:427-432
Objetivo: Este relato apresenta a evolução dos 100 primeiros pacientes transplantados na Unidade de Transplante de Medula Óssea do Hospital Português, no período de fevereiro de 2000 a novembro de 2005. Por ser pioneira na Bahia, e uma das únic
Autor:
T.A. Lane, A. Bashey, E. Carrier, P. Holman, J. Castro, M. Mullen, D.M. Ward, O. Ada, E.D. Ball
Publikováno v:
Cytotherapy. 6:318-327
The adequacy of HPC collection for BMT is typically assessed by the number of CD34 cells. However, during a series of leukapheresis procedures (LP) the CD34 value on the final HPC product may not be available for testing until late evening, sometimes
Autor:
Linda H. Yoder
Publikováno v:
Military Medicine. 163:661-666
There is a lack of published cost and outcome data concerning bone marrow transplant (BMT) patients treated in a military health care setting. The objectives of this prospective investigation were to collect demographic data concerning the characteri
Publikováno v:
Journal of Clinical Oncology. 16:2364-2370
PURPOSE To determine the cost of transfusing 2 units (U) of packed RBCs at a comprehensive cancer center. METHODS We performed a process-flow analysis to identify all costs of transfusing 2 U of allogeneic packed RBCs on an outpatient basis to patien
Autor:
Luciana Annino, Anna Maria Testi, Giovanna Meloni, Roberto Rondelli, William Arcese, Fiorina Giona, Maria Luisa Moleti, Franco Mandelli
Publikováno v:
Leukemia & Lymphoma. 32:89-95
Fifty-seven patients aged or = 15 (84% vs 50%, p=0.01 and 85% vs 54%, p = 0.02, respectively). Nineteen of 41 responders (46.3%) underwent bone marrow transplant (BMT) (10 autologous and 9 allogeneic). The estimated probabilities of event free surviv